Lacto-Free

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

tilactase, Quantity: 40 mg

Available from:

Care Pharmaceuticals Pty Ltd

INN (International Name):

Tilactase

Pharmaceutical form:

Tablet, uncoated

Composition:

Excipient Ingredients: magnesium stearate; povidone; silicon dioxide; microcrystalline cellulose

Administration route:

Oral

Therapeutic indications:

Decrease/reduce/relieve diarrhoea ; Decrease/reduce/relieve symptoms of lactose intolerance (Linked Indication:Helps reduce occurrence of diarrhoea; Reduce occurrence of excess intestinal wind/gas; Decrease/reduce/relieve excess intestinal gas; Aid/assist digestion of lactose; Helps reduce occurrence of abdominal bloating); Decrease/reduce/relieve abdominal spasm ; Helps reduce occurrence of abdominal spasm

Product summary:

Visual Identification: ; Container Type: Dispenser Pack; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Licence status A

Authorization date:

2014-06-19